Rentokil Initial PLC
LSE:RTO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
341.1
504.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Rentokil Initial PLC
Rentokil Initial PLC
Other Assets
Rentokil Initial PLC
Other Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Rentokil Initial PLC
LSE:RTO
|
Other Assets
£5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Mitie Group PLC
LSE:MTO
|
Other Assets
£361.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
|
Serco Group PLC
LSE:SRP
|
Other Assets
£938.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-3%
|
|
|
Renewi PLC
LSE:RWI
|
Other Assets
€568.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Kinovo PLC
LSE:KINO
|
Other Assets
£4.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
React Group PLC
LSE:REAT
|
Other Assets
£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Rentokil Initial PLC
Glance View
Rentokil Initial PLC is a global leader in pest control and hygiene services, founded more than 90 years ago in the United Kingdom. With a presence in over 70 countries, the company has fostered a reputation for innovation and reliability in managing health, hygiene, and environmental risks for businesses and households alike. Its comprehensive suite of services not only encompasses pest management but also includes solutions in washroom hygiene, infection prevention, and a range of essential facilities management services. As cities grow and public awareness of hygiene continues to rise, Rentokil's commitment to sustainability and technology-driven practices positions it as a crucial player in promoting public health and safety. For investors, Rentokil Initial presents a compelling opportunity, driven by robust demand for its essential services and a proven track record of strong financial performance. The company's strategic acquisitions, such as the recent purchase of Terminix, have broadened its market reach and enhanced its service offerings. This proactive growth strategy, combined with a resilient business model that thrives in both booming and challenging economic environments, underscores Rentokil's potential for long-term investment. With a focus on operational excellence and continuous improvement, Rentokil aims not just to meet market needs but to shape industry standards, making it a promising candidate for investors looking for stability and growth in the service sector.
See Also
What is Rentokil Initial PLC's Other Assets?
Other Assets
5B
GBP
Based on the financial report for Dec 31, 2023, Rentokil Initial PLC's Other Assets amounts to 5B GBP.
What is Rentokil Initial PLC's Other Assets growth rate?
Other Assets CAGR 5Y
34%
Over the last year, the Other Assets growth was -2%. The average annual Other Assets growth rates for Rentokil Initial PLC have been 46% over the past three years , 34% over the past five years .
You don't have any saved screeners yet
